Lung Opacity and Coronary Artery Calcium Score: A Combined Tool for Risk Stratification and Outcome Prediction in COVID-19 Patients.


Journal

Academic radiology
ISSN: 1878-4046
Titre abrégé: Acad Radiol
Pays: United States
ID NLM: 9440159

Informations de publication

Date de publication:
06 2022
Historique:
received: 08 02 2022
revised: 21 02 2022
accepted: 21 02 2022
pubmed: 30 3 2022
medline: 10 5 2022
entrez: 29 3 2022
Statut: ppublish

Résumé

To assess and correlate pulmonary involvement and outcome of SARS-CoV-2 pneumonia with the degree of coronary plaque burden based on the CAC-DRS classification (Coronary Artery Calcium Data and Reporting System). This retrospective study included 142 patients with confirmed SARS-CoV-2 pneumonia (58 ± 16 years; 57 women) who underwent non-contrast CT between January 2020 and August 2021 and were followed up for 129 ± 72 days. One experienced blinded radiologist analyzed CT series for the presence and extent of calcified plaque burden according to the visual and quantitative HU-based CAC-DRS Score. Pulmonary involvement was automatically evaluated with a dedicated software prototype by another two experienced radiologists and expressed as Opacity Score. CAC-DRS Scores derived from visual and quantitative image evaluation correlated well with the Opacity Score (r=0.81, 95% CI 0.76-0.86, and r=0.83, 95% CI 0.77-0.89, respectively; p<0.0001) with higher correlation in severe than in mild stage SARS-CoV-2 pneumonia (p<0.0001). Combined, CAC-DRS and Opacity Scores revealed great potential to discriminate fatal outcomes from a mild course of disease (AUC 0.938, 95% CI 0.89-0.97), and the need for intensive care treatment (AUC 0.801, 95% CI 0.77-0.83). Visual and quantitative CAC-DRS Scores provided independent prognostic information on all-cause mortality (p=0.0016 and p<0.0001, respectively), both in univariate and multivariate analysis. Coronary plaque burden is strongly correlated to pulmonary involvement, adverse outcome, and death due to respiratory failure in patients with SARS-CoV-2 pneumonia, offering great potential to identify individuals at high risk.

Identifiants

pubmed: 35346565
pii: S1076-6332(22)00129-5
doi: 10.1016/j.acra.2022.02.019
pmc: PMC8882413
pii:
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

861-870

Informations de copyright

Copyright © 2022 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Références

J Cardiovasc Comput Tomogr. 2021 Sep-Oct;15(5):421-430
pubmed: 33744175
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
PLoS One. 2014 Mar 13;9(3):e91239
pubmed: 24625525
JACC Cardiovasc Imaging. 2020 Nov;13(11):2468-2470
pubmed: 33153535
Eur Radiol. 2020 Aug;30(8):4417-4426
pubmed: 32279115
Ann Transl Med. 2020 May;8(9):576
pubmed: 32566603
J Am Coll Cardiol. 2011 Apr 12;57(15):1622-32
pubmed: 21439754
Front Pediatr. 2020 Nov 02;8:591132
pubmed: 33224909
JACC Cardiovasc Imaging. 2017 Aug;10(8):833-842
pubmed: 28797402
IEEE Trans Med Imaging. 2012 Dec;31(12):2322-34
pubmed: 22961297
Circ Cardiovasc Imaging. 2013 Jul;6(4):514-21
pubmed: 23756678
J Cardiovasc Comput Tomogr. 2018 May - Jun;12(3):185-191
pubmed: 29793848
Eur Radiol. 2020 Jun;30(6):3306-3309
pubmed: 32055945
J Thorac Dis. 2020 Oct;12(10):5783-5793
pubmed: 33209410
AJR Am J Roentgenol. 2021 Apr;216(4):860-873
pubmed: 33295802
J Cardiovasc Comput Tomogr. 2021 Jan-Feb;15(1):27-36
pubmed: 32952101
Eur Radiol. 2020 Jul;30(7):3684-3691
pubmed: 32144461
Radiology. 2020 Apr;295(1):202-207
pubmed: 32017661
J Cardiovasc Comput Tomogr. 2017 Mar - Apr;11(2):157-168
pubmed: 28283309
Atherosclerosis. 2021 Jul;328:136-143
pubmed: 33883086
Heart. 2020 Aug;106(15):1154-1159
pubmed: 32354798
Front Cardiovasc Med. 2021 Jul 09;8:684528
pubmed: 34307498
Radiographics. 2019 Sep-Oct;39(5):1435-1436
pubmed: 31498744
Clin Imaging. 2021 Jun;74:123-130
pubmed: 33485116
Radiology. 2020 Apr;295(1):21
pubmed: 32049602
PLoS One. 2021 Jul 21;16(7):e0255045
pubmed: 34288966
Int J Cardiol Heart Vasc. 2020 Jul 14;29:100583
pubmed: 32715080
Radiol Cardiothorac Imaging. 2020 Mar 30;2(2):e200047
pubmed: 33778560
Radiol Artif Intell. 2020 Jul 29;2(4):e200048
pubmed: 33928255
Arch Physiol Biochem. 2020 Jul 30;:1-13
pubmed: 32730095
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Clin Imaging. 2021 Sep;77:1-8
pubmed: 33601125
Acad Radiol. 2021 Aug;28(8):1048-1057
pubmed: 33741210
Radiology. 2020 Aug;296(2):E41-E45
pubmed: 32049601
J Am Coll Cardiol. 2019 Sep 10;74(10):e177-e232
pubmed: 30894318
J Cardiovasc Comput Tomogr. 2020 May - Jun;14(3):209-210
pubmed: 32423754
Chest. 2020 Jul;158(1):106-116
pubmed: 32275978

Auteurs

Vitali Koch (V)

Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Leon D Gruenewald (LD)

Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Moritz H Albrecht (MH)

Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Katrin Eichler (K)

Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Tatjana Gruber-Rouh (T)

Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Ibrahim Yel (I)

Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Leona S Alizadeh (LS)

Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Scherwin Mahmoudi (S)

Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Jan-Erik Scholtz (JE)

Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Simon S Martin (SS)

Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Lukas Lenga (L)

Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Thomas J Vogl (TJ)

Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Nour-Eldin A Nour-Eldin (NA)

Institute for Diagnostic and Interventional Radiology, Frankfurt University Hospital, Frankfurt, Germany; Department of Diagnostic and Interventional Radiology, Cairo University Hospital, Cairo, Egypt.

Florian Bienenfeld (F)

Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Renate M Hammerstingl (RM)

Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Christiana Graf (C)

Department of Internal Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.

Christof M Sommer (CM)

Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.

Stefan E Hardt (SE)

Department of Cardiology, Angiology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.

Silvio Mazziotti (S)

Department of Biomedical Sciences and Morphological and Functional Imaging, University Hospital Messina, Messina, Italy.

Giorgio Ascenti (G)

Department of Biomedical Sciences and Morphological and Functional Imaging, University Hospital Messina, Messina, Italy.

Giovanni Antonio Versace (GA)

Department of Clinical and Experimental Medicine, University Hospital Messina, Messina, Italy.

Tommaso D'Angelo (T)

Department of Biomedical Sciences and Morphological and Functional Imaging, University Hospital Messina, Messina, Italy; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands. Electronic address: tommasodang@gmail.com.

Christian Booz (C)

Division of Experimental Imaging, Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH